Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Vaughn

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Cancer Treatment Reports|December 1, 1977
Phase II evaluation of piperazinedione in metastatic breast carcinomaR L Palmer, B A Samal, C B Vaughn, et al.
Cancer Treatment Reports|May 1, 1981
Phase II evaluation of VP-16-213 in patients with advanced breast cancer: a Southwest Oncology Group StudyC B Vaughn, F Panettiere, T Thigpen, et al.
Oncology|January 1, 1980
Combination chemotherapy in advanced gastrointestinal malignancyC B Vaughn, P Brady, B J Chinn, et al.
Cancer Chemotherapy Reports|October 1, 1972
Further clinical trials with porfiromycin (NSC-56410) (large intermittent doses)R Izbicki, M al-Sarraf, M L Reed, et al.
Cancer Treatment Reports|March 1, 1983
Phase II evaluation of anguidine in central nervous system tumors: a southwest Oncology Group studyJ W Goodwin, R H Bottomley, C B Vaughn, et al.
Cancer Treatment Reports|February 1, 1984
High-dose methotrexate with leucovorin rescue plus vincristine in advanced sarcoma: a Southwest Oncology Group studyC B Vaughn, E McKelvey, S P Balcerzak, et al.
Cancer|February 1, 1974
Proceedings: Evaluation of combination vs. sequential cytotoxic chemotherapy in the treatment of advanced breast cancerL H Baker, C B Vaughn, M al-Sarraf, et al.
American Journal of Clinical Oncology|October 1, 1982
VP-16 and adriamycin in patients with advanced breast cancerC B Vaughn, E Maniscalco-Greb, C Lockhard, et al.
Breast Cancer Research and Treatment|December 1, 1989
Tissue ferritin concentration and prognosis in carcinoma of the breastR E Weinstein, B H Bond, B K Silberberg, et al.
Investigational New Drugs|January 1, 1984
Chlorozotocin: results in colorectal carcinoma treated with high and low doses. A Southwest Oncology Group studyC D Haas, J D McCracken, C B Vaughn, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Cancer Treatment Reports|December 1, 1977
Phase II evaluation of piperazinedione in metastatic breast carcinomaR L Palmer, B A Samal, C B Vaughn, et al.
Cancer Treatment Reports|May 1, 1981
Phase II evaluation of VP-16-213 in patients with advanced breast cancer: a Southwest Oncology Group StudyC B Vaughn, F Panettiere, T Thigpen, et al.
Oncology|January 1, 1980
Combination chemotherapy in advanced gastrointestinal malignancyC B Vaughn, P Brady, B J Chinn, et al.
Cancer Chemotherapy Reports|October 1, 1972
Further clinical trials with porfiromycin (NSC-56410) (large intermittent doses)R Izbicki, M al-Sarraf, M L Reed, et al.
Cancer Treatment Reports|March 1, 1983
Phase II evaluation of anguidine in central nervous system tumors: a southwest Oncology Group studyJ W Goodwin, R H Bottomley, C B Vaughn, et al.
Cancer Treatment Reports|February 1, 1984
High-dose methotrexate with leucovorin rescue plus vincristine in advanced sarcoma: a Southwest Oncology Group studyC B Vaughn, E McKelvey, S P Balcerzak, et al.
Cancer|February 1, 1974
Proceedings: Evaluation of combination vs. sequential cytotoxic chemotherapy in the treatment of advanced breast cancerL H Baker, C B Vaughn, M al-Sarraf, et al.
American Journal of Clinical Oncology|October 1, 1982
VP-16 and adriamycin in patients with advanced breast cancerC B Vaughn, E Maniscalco-Greb, C Lockhard, et al.
Breast Cancer Research and Treatment|December 1, 1989
Tissue ferritin concentration and prognosis in carcinoma of the breastR E Weinstein, B H Bond, B K Silberberg, et al.
Investigational New Drugs|January 1, 1984
Chlorozotocin: results in colorectal carcinoma treated with high and low doses. A Southwest Oncology Group studyC D Haas, J D McCracken, C B Vaughn, et al.
Pageof 5